Rapid effects of BCG on T cell function in cancer patients

[1]  E. Perlin,et al.  Association of depressed postoperative lymphoproliferative responses to alloantigens with poor prognosis in patients with stage I lung cancer , 1980, International journal of cancer.

[2]  B. Wahrén,et al.  Distribution of tumor‐associated antigen cea and cross‐reacting NCA in fetal organs , 1980, International journal of cancer.

[3]  R. Herberman,et al.  Increased monocyte‐mediated cytostasis of lymphoid cell lines in breast and lung cancer patients , 1979, International journal of cancer.

[4]  R. Kerman,et al.  Effect of BCG immunotherapy on the active-T and total T-RFC in patients with lung cancer , 1978, Cancer Immunology, Immunotherapy.

[5]  J. Djeu,et al.  Detection of decreased proportion of lymphocytes forming rosettes with sheep erythrocytes at 29 degrees C in the blood of cancer patients. Analysis of factors affecting the assay. , 1977, Clinical immunology and immunopathology.

[6]  R. Connor,et al.  The relative proliferation index as a more sensitive parameter for evaluating lymphoproliferative responses of cancer patients to mitogens and alloantigens , 1977, International journal of cancer.

[7]  K. Havemann,et al.  Cellular immune reactions in patients with bronchogenic carcinoma before and after radio-, chemo- and immunotherapy. , 1977, Zeitschrift fur Immunitatsforschung. Immunobiology.

[8]  J. R. Oehler,et al.  In vitro inhibition of lymphoproliferative responses to tumor associated antigens and of lymphoma cell proliferation by rat splenic macrophages. , 1977, Cellular immunology.

[9]  D. Morton,et al.  Sequential examination of lymphocyte proliferative capacity in patients with malignant melanoma receiving bcg immunotherapy , 1977, International journal of cancer.

[10]  J. Blom,et al.  Immunological monitoring and immunotherapy in carcinoma of the lung , 1976, International journal of cancer.

[11]  B. Dixon,et al.  The effect of Corynebacterium parvum on the humoral and cellular immune systems in patients with breast cancer. , 1976, Clinical and experimental immunology.

[12]  R. Herberman,et al.  Functional activities of rosette separated human peripheral blood leukocytes. , 1975, Journal of immunology.

[13]  R. Hahn,et al.  Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer. , 1975, Cancer research.

[14]  M. Jondal.  Surface Markers on Human B and T Lymphocytes , 1974, Scandinavian journal of immunology.

[15]  H. Kirchner,et al.  EVIDENCE OF SUPPRESSOR CELL ACTIVITY IN SPLEENS OF MICE BEARING PRIMARY TUMORS INDUCED BY MOLONEY SARCOMA VIRUS , 1974, The Journal of experimental medicine.

[16]  E. Henderson,et al.  Immunotherapy in previously treated acute lymphatic leukemia. , 1973, National Cancer Institute monograph.

[17]  D. Crowther,et al.  Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma a sequential study over 28 days. I. Changes in blood counts, serum immunoglobulins and lymphoid cell populations. , 1979, Clinical and experimental immunology.

[18]  R. Herberman,et al.  Performance of a rosette assay between lymphocytes and sheep erythrocytes at elevated temperatures to study patients with cancer and other diseases. , 1976, Clinical immunology and immunopathology.